💊 Geriatric Medication Reconciliation Discharge Simulator

Pre-Admission List & the Best Possible Medication History

Every reconciliation effort stands or falls on the accuracy of the starting point. The Best Possible Medication History (BPMH) is a structured process for building the single most accurate list of what a patient was actually taking before admission — not what the old chart says, not what one bottle label claims, but a triangulated truth from multiple sources. For older adults on complex regimens, this single step prevents more downstream harm than almost any other part of the hospital stay.

• ≥2: Sources required for a BPMH (patient/caregiver + pharmacy + chart)
• 8–12: Avg. meds per geriatric patient (chronic conditions, age 65+)
• ~67%: Patients with inaccurate charted list (at least one error on admission)
• 15–30 min: Time to complete a rigorous BPMH (pharmacist-led interview)

What a Best Possible Medication History actually requires

A BPMH is not simply copying the outpatient chart into the admission note. It is a structured interview combined with independent verification:

• Direct patient/caregiver interview: name, dose, route, frequency, and — critically — whether the patient actually takes it as prescribed (adherence gaps are common and rarely charted) • Pill bottles or a "brown bag" review: physically inspecting what is in the home • Community pharmacy fill history: objective refill/dispensing records, useful when patient recall is unreliable • Prior discharge summaries and outpatient EHR: cross-checked, not trusted alone • Over-the-counter drugs, supplements, and PRN (as-needed) medications: frequently omitted by patients who do not consider them "real" medications

At least two independent sources should agree before an item is accepted onto the BPMH. Any conflict between sources is itself a data point — it flags a medication that needs active clarification before it can be trusted.

Studies of admission medication histories have found that roughly two-thirds of hospitalized older adults have at least one error in their charted home medication list — most commonly an omission of a medication the patient was actually taking. The BPMH is the correction mechanism.

Why geriatric patients are the highest-stakes population

Older adults are disproportionately exposed to medication reconciliation failure for structural reasons, not just because they take more pills:

• Polypharmacy: patients over 65 average 8–12 chronic medications, often prescribed by multiple specialists who do not see each other's notes • Multiple prescribers and pharmacies: a cardiologist, a primary care physician, and a specialist may each independently manage overlapping therapy without a shared, current list • Cognitive and sensory barriers: memory impairment, hearing loss, and low health literacy make patient-reported histories less reliable — increasing dependence on caregivers and objective records • Altered pharmacokinetics: reduced renal clearance and hepatic metabolism mean dosing errors that a younger patient would tolerate can cause serious harm in an older one • Narrow-therapeutic-index drugs are common: anticoagulants, insulin, digoxin, and diuretics — all frequently prescribed in this population — have little margin between a therapeutic and a harmful dose

This is precisely why national safety programs single out care transitions, rather than routine outpatient refills, as the highest-leverage point for medication safety intervention.

The Joint Commission mandate

The Joint Commission's National Patient Safety Goal on medication reconciliation (NPSG.03.06.01) requires accredited hospitals to maintain and communicate accurate patient medication information across every transition of care — admission, transfer, and discharge. The goal explicitly requires:

1. Obtaining information on the medications the patient is currently taking, on arrival 2. Comparing that list against medications ordered for the patient while under the organization's care 3. Providing the patient (or family/caregiver) with written information on the medications to be taken after discharge 4. Explaining the importance of managing medication information whenever the patient transitions to a new setting

The standard exists because the alternative — informal, undocumented reconciliation — has been repeatedly shown to fail exactly at the moments patients are most vulnerable: on arrival confused and unwell, and on discharge rushed and overwhelmed.

In-Hospital Changes — How the Chart Drifts From the Home List

The moment a patient is admitted, their medication regimen begins to diverge from their home baseline — appropriately so. Acute problems require new drugs; home medications are held for surgery, renal function, or bleeding risk; doses are titrated to inpatient response. Each of these changes is clinically reasonable in isolation. The danger is that by discharge, nobody has kept a running, explicit account of exactly what changed and why.

• 2–9: Meds changed per admission (depending on length/complexity of stay)
• ~1 in 3: "Held" meds never restarted (common unintentional omission)
• 1–4: New meds started per stay (often continued unnecessarily post-discharge)
• 5.5 days: Avg. inpatient length of stay (65+) (more days, more drift)

The three ways a medication list drifts

In-hospital changes fall into three categories, each with a distinct discrepancy risk at discharge:

• Held or stopped medications: a diuretic held for acute kidney injury, an anticoagulant held for a procedure, a blood pressure medication stopped for hypotension. These are frequently held with a clear inpatient rationale — and then never explicitly re-addressed at discharge. The medication simply disappears from the active list with no documented decision either to resume or permanently discontinue it.

• Dose-adjusted medications: insulin titrated against inpatient glucose control, diuretics up-titrated for volume overload, antihypertensives adjusted for inpatient blood pressure trends. Inpatient dosing is calibrated to an acute, monitored environment — it is not automatically the correct outpatient dose, but it is frequently carried forward as if it were.

• Newly started medications: antibiotics, anticoagulation bridging, symptom-control agents (e.g., opioids, laxatives, PPIs for stress ulcer prophylaxis) started for the acute admission. Many of these have no ongoing outpatient indication once the acute issue resolves, yet without an active stop-decision they are simply carried onto the discharge list by default.

Stress-ulcer-prophylaxis PPIs and short-course opioids started during a hospital stay are among the most commonly and unnecessarily continued medications after discharge — a well-documented pattern sometimes called "prescribing inertia."

Why complexity compounds the risk

The relationship between length/complexity of stay and discrepancy risk is not linear — it compounds. Each additional day introduces new prescribers (rounding teams change, consultants are added), new acute issues, and more opportunities for a change to be made without full visibility into the original home list.

ICU stays, multiple service transfers within the same hospitalization, and multi-specialty co-management are particularly high-risk: each handoff between teams is itself a mini-transition where the same reconciliation failure modes can occur before the patient has even reached discharge.

This is why the Reconciliation Process Quality control in this simulator interacts with Hospital Stay Complexity multiplicatively rather than independently — a highly complex stay reconciled by a rigorous process still produces a clean list, but the same complexity paired with a rushed, low-quality reconciliation produces the highest discrepancy burden of all.

Discrepancy Detection — Finding What Changed and What Was Missed

Detection is the step where the admission BPMH and the draft discharge medication list are systematically compared, line by line, against each other. Every mismatch is a candidate discrepancy: a medication present on one list and absent from the other, a dose that changed without documented rationale, or — the classic and dangerous case — the same drug class appearing twice under different brand or generic names.

• ~50–70%: Patients with ≥1 discrepancy at transitions (across published reconciliation studies)
• ~30–40%: Discrepancies rated clinically significant (of those found, could cause harm)
• Omission: Most common discrepancy type (a home med simply dropped)
• ~20: ISMP high-alert drug classes (anticoagulants & insulin top the list)

What a discrepancy actually is — and isn't

Not every difference between the admission and discharge list is an error. An intentional discontinuation, clearly documented with clinical rationale, is a legitimate change, not a discrepancy. The literature distinguishes:

• Intentional, documented changes: a clinician explicitly decided to stop, start, or adjust a medication and recorded why. These are the goal of good inpatient care.

• Unintentional discrepancies: any difference between what the patient should be taking and what is actually ordered, without a documented clinical rationale. This is the category reconciliation exists to catch. Sub-types include: – Omission: a home medication silently dropped, with no plan to restart it – Duplication: the same therapeutic class ordered twice (e.g., a home statin plus a newly started statin under a different name) – Dose or frequency discrepancy: an inpatient-titrated dose carried forward as the permanent outpatient dose without re-evaluation – Drug interaction introduced: a new medication that conflicts with an unchanged home medication, neither flagged against the other

Published discrepancy prevalence studies consistently find that roughly half to seventy percent of patients have at least one unintended discrepancy at a care transition, and that a substantial minority of those are judged capable of causing patient harm if uncorrected.

The Institute for Safe Medication Practices (ISMP) designates anticoagulants, insulin, and opioids as "high-alert medications" — drugs that carry a heightened risk of causing significant patient harm when used in error, even though the errors themselves are no more frequent than with other drug classes. A single missed warfarin dose or duplicated insulin order at discharge is a textbook "never event" candidate.

The comparison gate — structured, not ad hoc

Effective discrepancy detection is a structured comparison, not a clinician skimming two lists side by side under time pressure. Reliable programs use:

• A standardized reconciliation form or electronic tool that forces an explicit disposition for every home medication: continue unchanged, continue with a modified dose, discontinue, or hold with a defined restart plan • Automated duplicate-therapy alerts that flag two active orders in the same drug class, regardless of brand/generic naming differences • A dedicated reconciliation step at every transition — not just final discharge — so drift is caught at each handoff rather than accumulating silently across an entire admission • Pharmacist involvement specifically at the comparison step, since pharmacists are trained to recognize therapeutic duplication and clinically significant interactions that a time-pressured physician workflow can miss

The quality of this comparison step is the single largest driver of how many real discrepancies are actually caught versus silently carried through to the patient's discharge bag.

Reconciliation Process — Resolving Every Flagged Item

Detection alone does not protect the patient — a flagged discrepancy that is never resolved is just a documented near-miss. The reconciliation process is the active work of closing each flagged item: confirming clinical intent, contacting the responsible prescriber when needed, and arriving at a single, unambiguous, verified medication order before the patient leaves the building.

• ↓ 30–50%: Pharmacist-led reconciliation programs (reduction in discrepancy rate vs. usual care)
• ~20%: Readmissions attributable to med errors (of 30-day readmissions, various studies)
• 5–15 min: Time per resolved discrepancy (prescriber contact, documentation)
• 2000s–present: BOOST / Project RED programs (landmark transition-of-care models)

Who does reconciliation, and why pharmacists move the needle

Reconciliation can be performed by physicians, nurses, or pharmacists, but a substantial body of evidence points to pharmacist-led reconciliation as the most effective single intervention for reducing discrepancy rates:

• Pharmacists bring focused pharmacologic training that lets them recognize duplicate therapy, interaction risk, and renal/hepatic dose adjustment needs faster than a generalist review • Dedicated time: unlike a physician managing an entire discharge (disposition, follow-up appointments, functional status, discharge summary), a pharmacist's reconciliation review is not competing with a dozen other discharge tasks in the same ten minutes • Direct prescriber contact: pharmacists are well-positioned to call the outpatient prescriber or specialist to confirm an ambiguous medication's intended status, closing the loop that a rushed inpatient team often skips

Meta-analyses of pharmacist-led medication reconciliation and discharge counseling programs have found reductions of roughly 30–50% in post-discharge medication discrepancies, alongside measurable reductions in medication-related emergency visits and readmissions in higher-risk populations.

Landmark transition-of-care models — Project RED (Re-Engineered Discharge) and Project BOOST (Better Outcomes for Older adults through Safe Transitions) — both place structured medication reconciliation, ideally pharmacist-verified, at the center of a safe discharge, alongside teach-back patient education and a scheduled follow-up contact.

Closing the loop on every flagged item

A rigorous resolution process works through every flagged discrepancy individually rather than batch-approving the list:

1. Confirm intent: was the change deliberate? If yes, was it documented with rationale — if not, document it now 2. Contact the source when ambiguous: call the outpatient prescriber, the patient's community pharmacy, or the family caregiver to clarify an unclear history 3. Resolve duplications explicitly: choose one active order for the drug class, discontinue the other, and document why 4. Reassess inpatient-titrated doses: does the inpatient dose reflect a stable outpatient target, or was it calibrated to an acute, monitored state that no longer applies? 5. Make an explicit decision on every held medication: resume at the original dose, resume at an adjusted dose, or discontinue permanently — "held" is never an acceptable final discharge status

Even with a strong process, not every flagged item resolves cleanly on the first pass — ambiguous cases sometimes require escalation or are carried forward with a documented follow-up plan rather than a guess.

Discharge & Follow-Up — Confirming the List Survives Contact With Home

A perfectly reconciled list on paper is not the same as a patient correctly taking their medications at home. The final stage closes the loop: the verified list is communicated clearly to the patient and caregiver, and a structured follow-up — typically a phone call or visit within about 72 hours — confirms the list was understood, the pharmacy filled it correctly, and the patient is actually taking what was prescribed.

• 24–72 h: Recommended follow-up window (post-discharge contact)
• ~40%: Patients who misunderstand discharge instructions (without teach-back verification)
• ~20–30%: 30-day readmission reduction (with structured follow-up + reconciliation)
• ~1 in 5: Preventable adverse drug events post-discharge (of all post-discharge adverse events)

Communicating the list — plain language, not a printout of chart codes

The discharge medication list handed to the patient must be legible and actionable by the patient and family, not simply an export of the EHR's internal formatting. Best practice includes:

• Plain-language drug names and purposes ("water pill for swelling," not just "furosemide 20mg PO BID") • Explicit indication of what changed and why: new medications, stopped medications, and dose changes each called out distinctly rather than buried in an undifferentiated alphabetical list • Teach-back verification: asking the patient or caregiver to explain, in their own words, what each medication is for and when to take it — not simply asking "any questions?" and accepting silence as understanding • A single, reconciled, dated document that supersedes any prior version, reducing the risk that an old printed list resurfaces and gets remixed with the new one at home

Why the follow-up contact is not optional

Reconciliation performed perfectly inside the hospital can still fail after discharge for reasons entirely outside the reconciliation process itself:

• The outpatient pharmacy may not stock the new medication, substituting or delaying a fill • The patient may resume an old, discontinued prescription bottle out of habit, effectively re-creating a duplication error at home • Cognitive or functional barriers (opening pill bottles, reading small print, managing a new pill organizer) may prevent correct administration even when the list itself is accurate • Insurance formulary restrictions may substitute an unfamiliar generic, causing confusion about whether it is a "new" medication

A follow-up call or visit within roughly 24–72 hours is the mechanism that catches these home-environment failures before they escalate to an emergency visit or readmission. Structured transition-of-care programs that pair rigorous inpatient reconciliation with this follow-up contact have demonstrated meaningfully lower 30-day readmission rates than reconciliation alone.

A substantial share of early post-discharge adverse events are medication-related and judged preventable — the follow-up call is often the only point at which a discrepancy that survived the inpatient process is finally caught, before it causes harm rather than after.